MCM3 and primary cutaneous T-cell non-Hodgkin lymphoma: The poor prognostic effect of MCM3 overexpression was also shown in gliomas, thyroid carcinomas, melanoma, cutaneous T-cell lymphomas and oral squamous cell carcinomas.19